These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24624545)

  • 1. The Cancer Genome Atlas: clinical applications for breast cancer.
    Ma CX; Ellis MJ
    Oncology (Williston Park); 2013 Dec; 27(12):1263-9, 1274-9. PubMed ID: 24624545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research and clinical applications of cancer genome sequencing.
    Ku CS; Cooper DN; Ziogas DE; Halkia E; Tzaphlidou M; Roukos DH
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):3-10. PubMed ID: 23108289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience with genomic profiling of heavily pretreated breast cancers.
    Staren ED; Braun D; Tan B; Gupta D; Kim S; Kramer K; Markman M
    Ann Surg Oncol; 2014 Oct; 21(10):3216-22. PubMed ID: 25047475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive genomic sequencing and the molecular profiles of clinically advanced breast cancer.
    Ross JS; Gay LM
    Pathology; 2017 Feb; 49(2):120-132. PubMed ID: 28034454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of mitochondrial DNA mutations by high-throughput sequencing in the blood of breast cancer patients.
    Li LH; Kang T; Chen L; Zhang W; Liao Y; Chen J; Shi Y
    Int J Mol Med; 2014 Jan; 33(1):77-82. PubMed ID: 24253185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of linkage analysis, genome-wide association studies, and next-generation sequencing in the identification of disease-causing mutations.
    Londin E; Yadav P; Surrey S; Kricka LJ; Fortina P
    Methods Mol Biol; 2013; 1015():127-46. PubMed ID: 23824853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
    Liu X; Wang J; Chen L
    Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing today.
    Euhus D
    Ann Surg Oncol; 2014 Oct; 21(10):3209-15. PubMed ID: 25029991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular classification of breast tumors: toward improved diagnostics and treatments.
    Sørlie T
    Methods Mol Biol; 2007; 360():91-114. PubMed ID: 17172726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next generation analysis of breast cancer genomes for precision medicine.
    Previati M; Manfrini M; Galasso M; Zerbinati C; Palatini J; Gasparini P; Volinia S
    Cancer Lett; 2013 Oct; 339(1):1-7. PubMed ID: 23879964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic point mutations occurring early in development: a monozygotic twin study.
    Li R; Montpetit A; Rousseau M; Wu SY; Greenwood CM; Spector TD; Pollak M; Polychronakos C; Richards JB
    J Med Genet; 2014 Jan; 51(1):28-34. PubMed ID: 24123875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating the TCGA breast cancer results into clinical practice: searching for therapeutic clues.
    Sparano JA; Golden AA; Montagna C
    Oncology (Williston Park); 2013 Dec; 27(12):1284, 1286. PubMed ID: 24624547
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cancer genome analysis through next-generation sequencing].
    Aburatani H
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):1-6. PubMed ID: 21368453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep sequencing and integrative genome analysis: approaching a new class of biomarkers and therapeutic targets for breast cancer.
    Zografos G; Liakakos T; Roukos DH
    Pharmacogenomics; 2013 Jan; 14(1):5-8. PubMed ID: 23252942
    [No Abstract]   [Full Text] [Related]  

  • 15. Genome-wide association and sequencing studies on colorectal cancer.
    Wong SH; Sung JJ; Chan FK; To KF; Ng SS; Wang XJ; Yu J; Wu WK
    Semin Cancer Biol; 2013 Dec; 23(6 Pt B):502-11. PubMed ID: 24096009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of high-throughput sequencing in oncology].
    Rodrigues MJ; Gomez-Roca C
    Bull Cancer; 2013 Mar; 100(3):295-301. PubMed ID: 23501647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep sequencing in cancer research.
    Yoshida K; Sanada M; Ogawa S
    Jpn J Clin Oncol; 2013 Feb; 43(2):110-5. PubMed ID: 23225907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer.
    Ozcelik H; Shi X; Chang MC; Tram E; Vlasschaert M; Di Nicola N; Kiselova A; Yee D; Goldman A; Dowar M; Sukhu B; Kandel R; Siminovitch K
    J Mol Diagn; 2012 Sep; 14(5):467-75. PubMed ID: 22874498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Epigenomic Revolution in Breast Cancer: From Single-Gene to Genome-Wide Next-Generation Approaches.
    Davalos V; Martinez-Cardus A; Esteller M
    Am J Pathol; 2017 Oct; 187(10):2163-2174. PubMed ID: 28734945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond BRCA1/2: polygenic, 'polyfunctional' molecular circuitry model to predict breast cancer risk.
    Lianos GD; Zoras O; Roukos DH
    Biomark Med; 2013 Oct; 7(5):675-8. PubMed ID: 24044557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.